30 /100
MEDIUM RISK
Score updated May 30, 2026

IDXG — Interpace Biosciences, Inc. Dilution Risk Tracker

Track IDXG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IDXG — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
80
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛅
Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.93 approaching $1 threshold
🔔 Track IDXG — Get forecast alerts →

💹 Market Data

Market Cap$47.09M
Shares Outstanding27.70M
Float2.85M
Cash$2.65M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest806
Days to Cover1.0
% of Float0.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022
xbrl XBRL WARRANT Dec 31, 2021
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track IDXG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IDXG — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for IDXG
📊 IDXG FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IDXG Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.